在比克斯塔夫的大脑干脑炎中发现的抗GM1抗体
Claire Hall1, Milan Hargovan-Lalloo2, Eleanor Taylor3
1General Medicine, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK claire.hall38@nhs.net.
BMJ case reports
|February 4, 2026
概括
这项研究报告了一个罕见的比克斯塔夫病例.
科学领域:
- 神经学 神经学
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- 比克斯塔夫脑干脑炎 (BBE) 是一种罕见的神经疾病.
- 坎比洛巴克特菌感染是吉林巴雷综合征 (GBS) 的已知触发因素之一.
- 坎皮洛巴克和BBE与抗GM1抗体之间的关联尚未得到充分证实.
研究的目的:
- 为了呈现一种独特的BBE病例,该病例是坎皮洛巴克特菌感染的次要病例.
- 为了突出这一特定案例的诊断发现.
- 在这种情况下,报告抗GM1抗体的存在.
主要方法:
- 临床诊断基于眼,动力衰退,意识减弱和反射症.
- 排除其他潜在的病理.
- 来自MRI,脑脊液分析和血清学测试的支持性证据.
主要成果:
- 一个确诊的BBE病例被诊断出.
- 患者出现了经典的BBE症状.
- 血清检测显示出阳性抗甘化体IgG GM1抗体.
结论:
- 这是第一个报告的BBE病例,该病例是坎皮洛巴克特菌感染的次要病例,具有阳性抗GM1抗体.
- 这一发现扩大了对坎皮洛巴克特相关神经系统综合征的理解.
- 需要进一步的研究来探索抗GM1抗体在坎皮洛巴克特诱导的BBE.BE中的作用.
更多相关视频
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
08:20Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
Published on: June 2, 2022
相关概念视频
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
